fentanyl has been researched along with Adverse Drug Event in 36 studies
Fentanyl: A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078)
fentanyl : A monocarboxylic acid amide resulting from the formal condensation of the aryl amino group of N-phenyl-1-(2-phenylethyl)piperidin-4-amine with propanoic acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We evaluated the efficacy of sublingual fentanyl tablet (SLF) for the treatment of BTP in opioid-tolerant patients with chronic musculoskeletal pain with neuropathic component in terms of relief of pain intensity and assessed whether hypothetical pain relief impacts on quality of life (QoL)." | 9.20 | Efficacy and safety of sublingual fentanyl tablets for the management of breakthrough pain in patients with chronic musculoskeletal pain with neuropathic component: multicenter prospective study. ( Camba-Rodríguez, A; Cánovas-Martínez, L; Carceller-Ruiz, JJ; De la Iglesia-López, A; Díaz-Parada, P; Domínguez-Suárez, E; Freire-Vila, E; Iglesias, BG; Illodo-Miramontes, G; López-Ulloa, B, 2015) |
| "We performed a systematic review to evaluate the current evidence for the use of fentanyl for the relief of breathlessness." | 8.89 | Fentanyl for the relief of refractory breathlessness: a systematic review. ( Gaertner, J; Köskeroglu, P; Simon, ST; Voltz, R, 2013) |
| " placebo in the first 30 minutes after dosing (FBT provided an 83% probability of superior pain relief, ODT 66%, and OTFC 73% vs." | 6.49 | Efficacy of rapid-onset oral fentanyl formulations vs. oral morphine for cancer-related breakthrough pain: a meta-analysis of comparative trials. ( Bennett, MI; Fullarton, JR; Jandhyala, R, 2013) |
| "Adverse drug reactions were registered in 3%." | 5.48 | Fentanyl buccal tablet for breakthrough cancer pain in clinical practice: results of the non-interventional prospective study ErkentNIS. ( Gneist, M; Landthaler, R; Masel, EK; Watzke, HH, 2018) |
| "Guidelines tend to consider morphine and morphine-like opioids comparable and interchangeable in the treatment of chronic cancer pain, but individual responses can vary." | 5.22 | Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized phase IV 'real life' trial on the variability of response to opioids. ( Apolone, G; Azzarello, G; Bandieri, E; Caraceni, A; Cavanna, L; Corli, O; Crispino, C; Di Gregorio, R; Dragani, TA; Floriani, I; Galli, F; Gamucci, T; Greco, MT; Iorno, V; Kaasa, S; Lipari, G; Luzzani, M; Montanari, M; Pacchioni, M; Pavesi, L; Reale, C; Roberto, A; Valenti, D, 2016) |
| " We evaluated the efficacy of sublingual fentanyl tablet (SLF) for the treatment of BTP in opioid-tolerant patients with chronic musculoskeletal pain with neuropathic component in terms of relief of pain intensity and assessed whether hypothetical pain relief impacts on quality of life (QoL)." | 5.20 | Efficacy and safety of sublingual fentanyl tablets for the management of breakthrough pain in patients with chronic musculoskeletal pain with neuropathic component: multicenter prospective study. ( Camba-Rodríguez, A; Cánovas-Martínez, L; Carceller-Ruiz, JJ; De la Iglesia-López, A; Díaz-Parada, P; Domínguez-Suárez, E; Freire-Vila, E; Iglesias, BG; Illodo-Miramontes, G; López-Ulloa, B, 2015) |
| "We performed a systematic review to evaluate the current evidence for the use of fentanyl for the relief of breathlessness." | 4.89 | Fentanyl for the relief of refractory breathlessness: a systematic review. ( Gaertner, J; Köskeroglu, P; Simon, ST; Voltz, R, 2013) |
| "Adjusting for covariates, both the total number of drug seizures and amount of cocaine seized (in dosage units per capita) positively predicted next-year opioid- and fentanyl-involved fatal overdose rates." | 4.12 | Supply-side predictors of fatal drug overdose in the Washington/Baltimore HIDTA region: 2016-2020. ( Bates, R; Carr, T; Lowder, EM; Peppard, L; Zhou, W, 2022) |
| "The incidence of delirium was compared among 114 patients who had started morphine, oxycodone, or fentanyl injection at Shizuoka Cancer Center between June 2012 and September 2014." | 3.85 | Incidence of Delirium Among Patients Having Cancer Injected With Different Opioids for the First Time. ( Ishikawa, H; Matsumoto, T; Mori, K; Omae, K; Osaka, I; Sato, T; Shino, M; Tanaka, R, 2017) |
| "The incidence of myoclonus was significantly lower in the nalmefene group (8." | 3.30 | Low-dose nalmefene pretreatment reduces etomidate-induced myoclonus: A randomized, double-blind controlled trial. ( Cao, H; Dai, F; Liu, Y; Lu, H; Shan, G; Yin, D, 2023) |
| "Naloxone is the primary opioid overdose reversal agent, but concern has been raised that naloxone is not efficacious against the pervasive illicit high potency opioids (i." | 2.82 | Treatment of opioid overdose: current approaches and recent advances. ( Britch, SC; Walsh, SL, 2022) |
| " Since information about potency and lethal dosage are frequently unknown, it is important to identify the new trends for further investigation on therapeutic use, toxicity and fatal doses, and implement public health measures." | 2.72 | A 2017-2019 Update on Acute Intoxications and Fatalities from Illicit Fentanyl and Analogs. ( Brunetti, P; Busardò, FP; Carlier, J; Giorgetti, R; Lo Faro, AF; Pirani, F, 2021) |
| " placebo in the first 30 minutes after dosing (FBT provided an 83% probability of superior pain relief, ODT 66%, and OTFC 73% vs." | 2.49 | Efficacy of rapid-onset oral fentanyl formulations vs. oral morphine for cancer-related breakthrough pain: a meta-analysis of comparative trials. ( Bennett, MI; Fullarton, JR; Jandhyala, R, 2013) |
| " Safe supply programs are required now more than ever to address the high rate of drug toxicity overdose deaths caused by illicit fentanyl and its analogues." | 1.72 | Investigating opioid preference to inform safe supply services: A cross sectional study. ( Buxton, JA; Ferguson, M; Lock, K; Papamihali, K; Parmar, A; Weng, A, 2022) |
| "Main adverse drug events were nausea and vomiting, somnolence, and confusion." | 1.72 | Tolerance of Fentanyl Pectin Nasal Spray for Procedural Pain in Geriatric Patients. ( Baudrant, M; Bedouch, P; Cracowski, JL; Drevet, S; Gavazzi, G; Gibert, P; Grevy, A; Maindet, C; Maljean, L; Mitha, N; Payen, M; Tiffet, T; Zerhouni, N, 2022) |
| " We sought to determine the risk of serious adverse events (SAEs) when oral azithromycin or intravenous/intramuscular fentanyl are used off-label compared to on-label in pediatric intensive care units (ICUs)." | 1.51 | Serious Adverse Events Associated with Off-Label Use of Azithromycin or Fentanyl in Children in Intensive Care Units: A Retrospective Chart Review. ( Avant, D; Doe, E; Fenn, NE; Lardieri, A; Lieu, P; McMahon, AW; Oshikoya, KA; Sood, BG; Taketomo, C; Van Driest, SL; Wharton, GT; Yen, L, 2019) |
| "Adverse drug reactions were registered in 3%." | 1.48 | Fentanyl buccal tablet for breakthrough cancer pain in clinical practice: results of the non-interventional prospective study ErkentNIS. ( Gneist, M; Landthaler, R; Masel, EK; Watzke, HH, 2018) |
| "57% of patients having complications (52 patients having 60 adverse events)." | 1.37 | Safety of intravenous sedation administered by the operating oral surgeon: the second 7 years of office practice. ( Rodgers, MS; Rodgers, SF, 2011) |
| "5 million adverse drug reaction (ADR) reports for 8620 drugs/biologics that are listed for 1191 Coding Symbols for Thesaurus of Adverse Reaction (COSTAR) terms of adverse effects." | 1.32 | Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. ( Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.78) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (11.11) | 29.6817 |
| 2010's | 18 (50.00) | 24.3611 |
| 2020's | 13 (36.11) | 2.80 |
| Authors | Studies |
|---|---|
| Matthews, EJ | 1 |
| Kruhlak, NL | 1 |
| Weaver, JL | 1 |
| Benz, RD | 1 |
| Contrera, JF | 1 |
| Liu, Z | 1 |
| Shi, Q | 1 |
| Ding, D | 1 |
| Kelly, R | 1 |
| Fang, H | 1 |
| Tong, W | 1 |
| Del Pozo, B | 1 |
| Rich, JD | 1 |
| Carroll, JJ | 1 |
| Yeo, Y | 1 |
| Johnson, R | 1 |
| Heng, C | 1 |
| Ferguson, M | 1 |
| Parmar, A | 1 |
| Papamihali, K | 1 |
| Weng, A | 1 |
| Lock, K | 1 |
| Buxton, JA | 1 |
| Britch, SC | 1 |
| Walsh, SL | 1 |
| Maljean, L | 1 |
| Gavazzi, G | 1 |
| Gibert, P | 1 |
| Grevy, A | 1 |
| Payen, M | 1 |
| Zerhouni, N | 1 |
| Tiffet, T | 1 |
| Cracowski, JL | 1 |
| Mitha, N | 1 |
| Maindet, C | 1 |
| Baudrant, M | 1 |
| Bedouch, P | 1 |
| Drevet, S | 1 |
| Dyer, O | 1 |
| Palamar, JJ | 1 |
| Cottler, LB | 1 |
| Goldberger, BA | 1 |
| Severtson, SG | 1 |
| Grundy, DJ | 1 |
| Iwanicki, JL | 1 |
| Ciccarone, D | 1 |
| Lowder, EM | 1 |
| Zhou, W | 1 |
| Peppard, L | 1 |
| Bates, R | 1 |
| Carr, T | 1 |
| Ellefsen, KN | 1 |
| Smith, CR | 1 |
| Taylor, EA | 1 |
| Hall, BJ | 1 |
| Chatterton, CN | 1 |
| Handy, RP | 1 |
| Shan, G | 1 |
| Lu, H | 1 |
| Dai, F | 1 |
| Liu, Y | 1 |
| Yin, D | 1 |
| Cao, H | 1 |
| Zhong, L | 1 |
| Li, H | 1 |
| Zhao, B | 1 |
| Brunetti, P | 1 |
| Pirani, F | 1 |
| Carlier, J | 1 |
| Giorgetti, R | 1 |
| Busardò, FP | 1 |
| Lo Faro, AF | 1 |
| Fleet, JA | 1 |
| Jones, M | 1 |
| Belan, I | 1 |
| Masel, EK | 1 |
| Landthaler, R | 1 |
| Gneist, M | 1 |
| Watzke, HH | 1 |
| Breivik, H | 1 |
| Karila, L | 1 |
| Marillier, M | 1 |
| Chaumette, B | 1 |
| Billieux, J | 1 |
| Franchitto, N | 1 |
| Benyamina, A | 1 |
| Oshikoya, KA | 1 |
| Wharton, GT | 1 |
| Avant, D | 1 |
| Van Driest, SL | 1 |
| Fenn, NE | 1 |
| Lardieri, A | 1 |
| Doe, E | 1 |
| Sood, BG | 1 |
| Taketomo, C | 1 |
| Lieu, P | 1 |
| Yen, L | 1 |
| McMahon, AW | 1 |
| Simon, ST | 1 |
| Köskeroglu, P | 1 |
| Gaertner, J | 1 |
| Voltz, R | 1 |
| Cuervo Pinna, MÁ | 1 |
| Cánovas-Martínez, L | 1 |
| Carceller-Ruiz, JJ | 1 |
| Díaz-Parada, P | 1 |
| Illodo-Miramontes, G | 1 |
| Freire-Vila, E | 1 |
| De la Iglesia-López, A | 1 |
| Iglesias, BG | 1 |
| López-Ulloa, B | 1 |
| Domínguez-Suárez, E | 1 |
| Camba-Rodríguez, A | 1 |
| Shastay, A | 1 |
| Corli, O | 1 |
| Floriani, I | 1 |
| Roberto, A | 1 |
| Montanari, M | 1 |
| Galli, F | 1 |
| Greco, MT | 1 |
| Caraceni, A | 1 |
| Kaasa, S | 1 |
| Dragani, TA | 1 |
| Azzarello, G | 1 |
| Luzzani, M | 1 |
| Cavanna, L | 1 |
| Bandieri, E | 1 |
| Gamucci, T | 1 |
| Lipari, G | 1 |
| Di Gregorio, R | 1 |
| Valenti, D | 1 |
| Reale, C | 1 |
| Pavesi, L | 1 |
| Iorno, V | 1 |
| Crispino, C | 1 |
| Pacchioni, M | 1 |
| Apolone, G | 1 |
| Tanaka, R | 1 |
| Ishikawa, H | 1 |
| Sato, T | 1 |
| Shino, M | 1 |
| Matsumoto, T | 1 |
| Mori, K | 1 |
| Omae, K | 1 |
| Osaka, I | 1 |
| Mora, AG | 1 |
| Ganem, VJ | 1 |
| Ervin, AT | 1 |
| Maddry, JK | 1 |
| Bebarta, VS | 1 |
| Sande, TA | 1 |
| Laird, BJ | 1 |
| Fallon, MT | 1 |
| Chrysostomou, C | 1 |
| Sanchez De Toledo, J | 1 |
| Avolio, T | 1 |
| Motoa, MV | 1 |
| Berry, D | 1 |
| Morell, VO | 1 |
| Orr, R | 1 |
| Munoz, R | 1 |
| Jacobsen, R | 1 |
| Møldrup, C | 1 |
| Christrup, L | 1 |
| Stammschulte, T | 1 |
| Brune, K | 1 |
| Rodgers, SF | 1 |
| Rodgers, MS | 1 |
| Jenerowicz, D | 1 |
| Polańska, A | 1 |
| Olek-Hrab, K | 1 |
| Silny, W | 1 |
| Jandhyala, R | 1 |
| Fullarton, JR | 1 |
| Bennett, MI | 1 |
| Stuerenburg, HJ | 1 |
| Claassen, J | 1 |
| Eggers, C | 1 |
| Hansen, HC | 1 |
| Ndiritu, CG | 1 |
| Enos, LR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Morphine or Fentanyl for Refractory Dyspnea in COPD[NCT03834363] | Phase 4 | 60 participants (Anticipated) | Interventional | 2019-11-15 | Recruiting | ||
| An Observational Study to Assess the Efficacy, Safety, and Tolerability of Abstral Oral Disintegrating Tablet (ODT) for the Management of Breakthrough Cancer Pain in Korean Cancer Patients[NCT03895762] | 143 participants (Actual) | Observational | 2017-07-04 | Completed | |||
| RCT Comparing the Analgesic Efficacy of 4 Therapeutic Strategies Based on 4 Different Major Opioids (Fentanyl, Oxycodone, Buprenorphine vs Morphine) in Cancer Patients With Moderate/Severe Pain, at the Moment of Starting 3rd Step of WHO Analgesic Ladder.[NCT01809106] | Phase 4 | 518 participants (Actual) | Interventional | 2011-04-30 | Completed | ||
| Pharmacokinetic-pharmacodynamic Analysis for Dosing Strategy and Evaluation of Safety and Efficacy of Dexmedetomidine in Children[NCT04027829] | Phase 2 | 13 participants (Actual) | Interventional | 2019-08-14 | Completed | ||
| Efficacy of Injectable Fentanyl in Sublingual Route Versus Oral Morphine Syrup for Breakthrough Pain in Gynecologic Cancer Patients With Chronic Cancer Pain : A Randomized Double Blind Controlled Trial[NCT05037539] | Phase 1/Phase 2 | 20 participants (Actual) | Interventional | 2021-06-15 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Evaluation of the proportion of subjects who report full analgesia (full responders: FR). FR is operationally defined as a patient with a P.I.D. =/> 30% from visit 6 and visit 1 (NRS 0 to 10). (NCT01809106)
Timeframe: 28 days
| Intervention | participants (Number) |
|---|---|
| Morphine | 89 |
| Oxycodone | 90 |
| Buprenorphine | 95 |
| Fentanyl | 88 |
"Evaluation of the proportion of Non-Responder (NR) participants. NR correspond to the subjects who do not report any analgesic effects, with a P.I.D. (pain intensity difference) from visit 6 and visit 1 =/< 0%, (using a 0-10 NRS ). It includes the situations of average pain intensity stable or worsened at day 28 compared with baseline values." (NCT01809106)
Timeframe: 28 days
| Intervention | participants (Number) |
|---|---|
| Morphine | 14 |
| Oxycodone | 18 |
| Buprenorphine | 14 |
| Fentanyl | 11 |
The proportion of subjects with an increase of opioid daily dose > 5% compared with the basal dosage (OEI%). (NCT01809106)
Timeframe: 28 days
| Intervention | participants (Number) |
|---|---|
| Morphine | 13 |
| Oxycodone | 24 |
| Buprenorphine | 18 |
| Fentanyl | 45 |
8 reviews available for fentanyl and Adverse Drug Event
| Article | Year |
|---|---|
Treatment of opioid overdose: current approaches and recent advances.
Topics: Analgesics, Opioid; Drug Overdose; Drug-Related Side Effects and Adverse Reactions; Fentanyl; Humans | 2022 |
Fentanyl concentrations in ligated femoral blood in the presence and absence of NPS benzodiazepine drugs. A review of over 1250 benzo-dope / fentanyl toxicity cases in Alberta, Canada.
Topics: Alberta; Analgesics, Opioid; Autopsy; Drug Overdose; Drug-Related Side Effects and Adverse Reactions | 2023 |
A 2017-2019 Update on Acute Intoxications and Fatalities from Illicit Fentanyl and Analogs.
Topics: Analgesics, Opioid; Drug-Related Side Effects and Adverse Reactions; Fentanyl; Humans; Substance-Rel | 2021 |
New synthetic opioids: Part of a new addiction landscape.
Topics: Analgesics, Opioid; Behavioral Symptoms; Drug-Related Side Effects and Adverse Reactions; Fentanyl; | 2019 |
Fentanyl for the relief of refractory breathlessness: a systematic review.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Chronic Disease; Drug-Related Side E | 2013 |
The use of opioids in cancer patients with renal impairment-a systematic review.
Topics: Analgesics, Opioid; Drug-Related Side Effects and Adverse Reactions; Fentanyl; Humans; Neoplasms; Pa | 2017 |
Skin hypersensitivity reactions to transdermal therapeutic systems--still an important clinical problem.
Topics: Administration, Cutaneous; Dermatitis, Contact; Drug Delivery Systems; Drug Eruptions; Drug-Related | 2012 |
Efficacy of rapid-onset oral fentanyl formulations vs. oral morphine for cancer-related breakthrough pain: a meta-analysis of comparative trials.
Topics: Administration, Oral; Analgesics, Opioid; Breakthrough Pain; Causality; Comorbidity; Controlled Clin | 2013 |
4 trials available for fentanyl and Adverse Drug Event
| Article | Year |
|---|---|
Low-dose nalmefene pretreatment reduces etomidate-induced myoclonus: A randomized, double-blind controlled trial.
Topics: Anesthesia, General; Cough; Drug-Related Side Effects and Adverse Reactions; Etomidate; Fentanyl; Hu | 2023 |
Taking the alternative route: Women's experience of intranasal fentanyl, subcutaneous fentanyl or intramuscular pethidine for labour analgesia.
Topics: Administration, Intranasal; Adult; Analgesics; Drug-Related Side Effects and Adverse Reactions; Fema | 2017 |
Efficacy and safety of sublingual fentanyl tablets for the management of breakthrough pain in patients with chronic musculoskeletal pain with neuropathic component: multicenter prospective study.
Topics: Administration, Sublingual; Adult; Aged; Aged, 80 and over; Breakthrough Pain; Drug-Related Side Eff | 2015 |
Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized phase IV 'real life' trial on the variability of response to opioids.
Topics: Adult; Aged; Analgesics, Opioid; Cancer Pain; Drug-Related Side Effects and Adverse Reactions; Femal | 2016 |
Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized phase IV 'real life' trial on the variability of response to opioids.
Topics: Adult; Aged; Analgesics, Opioid; Cancer Pain; Drug-Related Side Effects and Adverse Reactions; Femal | 2016 |
Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized phase IV 'real life' trial on the variability of response to opioids.
Topics: Adult; Aged; Analgesics, Opioid; Cancer Pain; Drug-Related Side Effects and Adverse Reactions; Femal | 2016 |
Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized phase IV 'real life' trial on the variability of response to opioids.
Topics: Adult; Aged; Analgesics, Opioid; Cancer Pain; Drug-Related Side Effects and Adverse Reactions; Femal | 2016 |
24 other studies available for fentanyl and Adverse Drug Event
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Dru | 2004 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Da | 2011 |
Reports of accidental fentanyl overdose among police in the field: Toward correcting a harmful culture-bound syndrome.
Topics: Analgesics, Opioid; Drug Overdose; Drug-Related Side Effects and Adverse Reactions; Fentanyl; Humans | 2022 |
The Public Health Approach to the Worsening Opioid Crisis in the United States Calls for Harm Reduction Strategies to Mitigate the Harm From Opioid Addiction and Overdose Deaths.
Topics: Analgesics, Opioid; Drug Overdose; Drug-Related Side Effects and Adverse Reactions; Fentanyl; Harm R | 2022 |
Investigating opioid preference to inform safe supply services: A cross sectional study.
Topics: Adult; Analgesics, Opioid; British Columbia; Cross-Sectional Studies; Drug Overdose; Drug-Related Si | 2022 |
Tolerance of Fentanyl Pectin Nasal Spray for Procedural Pain in Geriatric Patients.
Topics: Aged; Analgesics, Opioid; Drug-Related Side Effects and Adverse Reactions; Fentanyl; Humans; Nasal S | 2022 |
Ohio doctor is acquitted of murdering 14 intensive care patients with fentanyl overdoses.
Topics: Critical Care; Drug Overdose; Drug-Related Side Effects and Adverse Reactions; Fentanyl; Humans; Ohi | 2022 |
Trends in characteristics of fentanyl-related poisonings in the United States, 2015-2021.
Topics: Adolescent; Adult; Analgesics, Opioid; Drug Overdose; Drug-Related Side Effects and Adverse Reaction | 2022 |
Supply-side predictors of fatal drug overdose in the Washington/Baltimore HIDTA region: 2016-2020.
Topics: Analgesics, Opioid; Drug Overdose; Drug Trafficking; Drug-Related Side Effects and Adverse Reactions | 2022 |
Emergence of fentanyl-related deaths in Travis County, Texas and surrounding areas: A retrospective review of postmortem fentanyl-related drug toxicities from 2020 to 2022.
Topics: Alprazolam; Analgesics, Opioid; Drug Overdose; Drug-Related Side Effects and Adverse Reactions; Fent | 2023 |
Comparison of Ketamine Alone and Subanesthetic Dose of Ketamine-Fentanyl for Regional Anesthesia in Children.
Topics: Administration, Intravenous; Analgesia; Anesthesia, Intravenous; Child; Child, Preschool; Drug-Relat | 2020 |
Fentanyl buccal tablet for breakthrough cancer pain in clinical practice: results of the non-interventional prospective study ErkentNIS.
Topics: Administration, Buccal; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Breakthrough Pain; Cance | 2018 |
A case-history illustrates importance of knowledge of drug-interactions when pain-patients are prescribed non-pain drugs for co-morbidities.
Topics: Aged; Comorbidity; Diclofenac; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; F | 2017 |
Serious Adverse Events Associated with Off-Label Use of Azithromycin or Fentanyl in Children in Intensive Care Units: A Retrospective Chart Review.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Analgesics, Opioid; Anti-Bacterial Ag | 2019 |
A randomized crossover clinical trial to evaluate the efficacy of oral transmucosal fentanyl citrate in the treatment of dyspnea on exertion in patients with advanced cancer.
Topics: Drug-Related Side Effects and Adverse Reactions; Dyspnea; Female; Fentanyl; Humans; Male; Patient Sa | 2014 |
Actiq Is Not for Sore Throats!
Topics: Administration, Topical; Drug-Related Side Effects and Adverse Reactions; Female; Fentanyl; Humans; | 2016 |
Incidence of Delirium Among Patients Having Cancer Injected With Different Opioids for the First Time.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Cancer Pain; Delirium; Drug-Related Side Effects | 2017 |
En Route Use of Analgesics in Nonintubated, Critically Ill Patients Transported by U.S. Air Force Critical Care Air Transport Teams.
Topics: Adult; Aerospace Medicine; Afghan Campaign 2001-; Air Ambulances; Analgesics; Critical Care; Critica | 2016 |
Dexmedetomidine use in a pediatric cardiac intensive care unit: can we use it in infants after cardiac surgery?
Topics: Age Factors; Analgesics, Non-Narcotic; Analgesics, Opioid; Dexmedetomidine; Dose-Response Relationsh | 2009 |
Danish pain specialists' rationales behind the choice of fentanyl transdermal patches and oral transmucosal systems--a delphi study.
Topics: Administration, Cutaneous; Administration, Oral; Analgesics, Opioid; Data Collection; Decision Suppo | 2009 |
[Drug safety problems in association with the use of opioid containing patches for the management of pain].
Topics: Administration, Cutaneous; Adult; Aged, 80 and over; Analgesics, Opioid; Drug Overdose; Drug-Related | 2010 |
Safety of intravenous sedation administered by the operating oral surgeon: the second 7 years of office practice.
Topics: Adult; Aged; Ambulatory Surgical Procedures; Anesthesia, Dental; Anesthetics, Intravenous; Conscious | 2011 |
Acute adverse reaction to fentanyl in a 55 year old man.
Topics: Cerebral Angiography; Chest Pain; Coma; Confusion; Diagnosis, Differential; Drug-Related Side Effect | 2000 |
Adverse reactions to drugs in a veterinary hospital.
Topics: Amphotericin B; Anaphylaxis; Animals; Cat Diseases; Cats; Cattle; Cattle Diseases; Chloral Hydrate; | 1977 |